Loading
Latest filing published 15 Apr 2026 for 동성제약, €4.9M.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 아이비케이금융그룹-유암코 중기도약 펀드 in 동성제약. In total, 2 filings cover trades dated from 31 March 2026 to 9 April 2026.
The open-market record is one-sided, with 2 purchases worth €9.8M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 15 April 2026, reports an open-market purchase of €4.9M in 동성제약. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations